nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—atherosclerosis—type 2 diabetes mellitus	0.26	0.649	CtDrD
Lovastatin—coronary artery disease—type 2 diabetes mellitus	0.14	0.351	CtDrD
Lovastatin—HMGCR—type 2 diabetes mellitus	0.12	0.601	CbGaD
Lovastatin—ABCC2—type 2 diabetes mellitus	0.0551	0.276	CbGaD
Lovastatin—CYP3A4—type 2 diabetes mellitus	0.0243	0.122	CbGaD
Lovastatin—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0185	0.0692	CbGbCtD
Lovastatin—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0122	0.0456	CbGbCtD
Lovastatin—UGT1A3—Losartan—type 2 diabetes mellitus	0.0119	0.0446	CbGbCtD
Lovastatin—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.011	0.0412	CbGbCtD
Lovastatin—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0104	0.0389	CbGbCtD
Lovastatin—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0102	0.038	CbGbCtD
Lovastatin—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.009	0.0336	CbGbCtD
Lovastatin—UGT2B7—Losartan—type 2 diabetes mellitus	0.00864	0.0322	CbGbCtD
Lovastatin—UGT1A1—Losartan—type 2 diabetes mellitus	0.00746	0.0279	CbGbCtD
Lovastatin—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00646	0.0241	CbGbCtD
Lovastatin—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.00599	0.0224	CbGbCtD
Lovastatin—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00517	0.0193	CbGbCtD
Lovastatin—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00516	0.0193	CbGbCtD
Lovastatin—ABCC2—Glyburide—type 2 diabetes mellitus	0.00496	0.0185	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00491	0.0183	CbGbCtD
Lovastatin—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00491	0.0183	CbGbCtD
Lovastatin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00491	0.0183	CbGbCtD
Lovastatin—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00467	0.0174	CbGbCtD
Lovastatin—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00461	0.0172	CbGbCtD
Lovastatin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00451	0.0168	CbGbCtD
Lovastatin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00437	0.0163	CbGbCtD
Lovastatin—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00431	0.0161	CbGbCtD
Lovastatin—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00416	0.0155	CbGbCtD
Lovastatin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00412	0.0154	CbGbCtD
Lovastatin—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00392	0.0146	CbGbCtD
Lovastatin—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00392	0.0146	CbGbCtD
Lovastatin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00383	0.0143	CbGbCtD
Lovastatin—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00368	0.0137	CbGbCtD
Lovastatin—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00362	0.0135	CbGbCtD
Lovastatin—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00349	0.013	CbGbCtD
Lovastatin—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00339	0.0127	CbGbCtD
Lovastatin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00326	0.0122	CbGbCtD
Lovastatin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00326	0.0122	CbGbCtD
Lovastatin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00316	0.0118	CbGbCtD
Lovastatin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00301	0.0112	CbGbCtD
Lovastatin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00298	0.0111	CbGbCtD
Lovastatin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00294	0.011	CbGbCtD
Lovastatin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0029	0.0108	CbGbCtD
Lovastatin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00275	0.0103	CbGbCtD
Lovastatin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00266	0.00992	CbGbCtD
Lovastatin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00262	0.00978	CbGbCtD
Lovastatin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00247	0.00922	CbGbCtD
Lovastatin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0024	0.00895	CbGbCtD
Lovastatin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00237	0.00884	CbGbCtD
Lovastatin—CYP3A5—Losartan—type 2 diabetes mellitus	0.00227	0.00849	CbGbCtD
Lovastatin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00226	0.00843	CbGbCtD
Lovastatin—CYP2C8—Losartan—type 2 diabetes mellitus	0.00219	0.00817	CbGbCtD
Lovastatin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00217	0.00811	CbGbCtD
Lovastatin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00216	0.00808	CbGbCtD
Lovastatin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00209	0.00782	CbGbCtD
Lovastatin—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00201	0.00749	CbGbCtD
Lovastatin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00189	0.00707	CbGbCtD
Lovastatin—CYP2C19—Losartan—type 2 diabetes mellitus	0.00183	0.00685	CbGbCtD
Lovastatin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00167	0.00623	CbGbCtD
Lovastatin—ITGAL—endothelium—type 2 diabetes mellitus	0.00166	0.102	CbGeAlD
Lovastatin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00162	0.00604	CbGbCtD
Lovastatin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00153	0.0057	CbGbCtD
Lovastatin—ABCB1—Losartan—type 2 diabetes mellitus	0.00148	0.00553	CbGbCtD
Lovastatin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00144	0.00536	CbGbCtD
Lovastatin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00138	0.00514	CbGbCtD
Lovastatin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00138	0.00514	CbGbCtD
Lovastatin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0013	0.00486	CbGbCtD
Lovastatin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00097	0.00362	CbGbCtD
Lovastatin—PON3—islet of Langerhans—type 2 diabetes mellitus	0.000925	0.0569	CbGeAlD
Lovastatin—CYP3A4—Losartan—type 2 diabetes mellitus	0.000887	0.00331	CbGbCtD
Lovastatin—ITGAL—cardiovascular system—type 2 diabetes mellitus	0.000682	0.042	CbGeAlD
Lovastatin—PON3—pancreas—type 2 diabetes mellitus	0.00065	0.04	CbGeAlD
Lovastatin—ITGAL—adipose tissue—type 2 diabetes mellitus	0.000602	0.037	CbGeAlD
Lovastatin—PON3—adipose tissue—type 2 diabetes mellitus	0.00059	0.0363	CbGeAlD
Lovastatin—Simvastatin—HMGCR—type 2 diabetes mellitus	0.000582	0.304	CrCbGaD
Lovastatin—Pravastatin—HMGCR—type 2 diabetes mellitus	0.00057	0.297	CrCbGaD
Lovastatin—ITGAL—liver—type 2 diabetes mellitus	0.000422	0.026	CbGeAlD
Lovastatin—PON3—liver—type 2 diabetes mellitus	0.000414	0.0255	CbGeAlD
Lovastatin—HDAC2—islet of Langerhans—type 2 diabetes mellitus	0.000377	0.0232	CbGeAlD
Lovastatin—UGT1A3—liver—type 2 diabetes mellitus	0.000359	0.0221	CbGeAlD
Lovastatin—HMGCR—islet of Langerhans—type 2 diabetes mellitus	0.00034	0.0209	CbGeAlD
Lovastatin—UGT2B7—kidney—type 2 diabetes mellitus	0.000326	0.0201	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000325	0.02	CbGeAlD
Lovastatin—HDAC2—retina—type 2 diabetes mellitus	0.000322	0.0198	CbGeAlD
Lovastatin—HDAC2—nephron tubule—type 2 diabetes mellitus	0.000304	0.0187	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000278	0.0171	CbGeAlD
Lovastatin—UGT1A1—kidney—type 2 diabetes mellitus	0.000277	0.0171	CbGeAlD
Lovastatin—HMGCR—nephron tubule—type 2 diabetes mellitus	0.000274	0.0169	CbGeAlD
Lovastatin—HDAC2—cardiovascular system—type 2 diabetes mellitus	0.000273	0.0168	CbGeAlD
Lovastatin—Simvastatin—ABCC2—type 2 diabetes mellitus	0.000268	0.14	CrCbGaD
Lovastatin—HDAC2—kidney—type 2 diabetes mellitus	0.000267	0.0164	CbGeAlD
Lovastatin—HDAC2—pancreas—type 2 diabetes mellitus	0.000265	0.0163	CbGeAlD
Lovastatin—Pravastatin—ABCC2—type 2 diabetes mellitus	0.000262	0.137	CrCbGaD
Lovastatin—HDAC2—cortex of kidney—type 2 diabetes mellitus	0.00026	0.016	CbGeAlD
Lovastatin—HMGCR—cardiovascular system—type 2 diabetes mellitus	0.000246	0.0151	CbGeAlD
Lovastatin—HMGCR—kidney—type 2 diabetes mellitus	0.000241	0.0148	CbGeAlD
Lovastatin—HDAC2—adipose tissue—type 2 diabetes mellitus	0.00024	0.0148	CbGeAlD
Lovastatin—HMGCR—pancreas—type 2 diabetes mellitus	0.000239	0.0147	CbGeAlD
Lovastatin—HMGCR—cortex of kidney—type 2 diabetes mellitus	0.000234	0.0144	CbGeAlD
Lovastatin—SLCO1B1—kidney—type 2 diabetes mellitus	0.000231	0.0142	CbGeAlD
Lovastatin—HMGCR—adipose tissue—type 2 diabetes mellitus	0.000217	0.0134	CbGeAlD
Lovastatin—CYP3A7—liver—type 2 diabetes mellitus	0.000213	0.0131	CbGeAlD
Lovastatin—UGT2B7—liver—type 2 diabetes mellitus	0.000206	0.0127	CbGeAlD
Lovastatin—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000199	0.0122	CbGeAlD
Lovastatin—SLCO1A2—kidney—type 2 diabetes mellitus	0.000188	0.0116	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000181	0.0111	CbGeAlD
Lovastatin—UGT1A1—liver—type 2 diabetes mellitus	0.000175	0.0108	CbGeAlD
Lovastatin—ABCC2—kidney—type 2 diabetes mellitus	0.000175	0.0108	CbGeAlD
Lovastatin—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.00017	0.0105	CbGeAlD
Lovastatin—HDAC2—liver—type 2 diabetes mellitus	0.000169	0.0104	CbGeAlD
Lovastatin—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000167	0.0103	CbGeAlD
Lovastatin—HMGCR—liver—type 2 diabetes mellitus	0.000152	0.00936	CbGeAlD
Lovastatin—SLCO1B1—liver—type 2 diabetes mellitus	0.000146	0.00897	CbGeAlD
Lovastatin—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000135	0.00829	CbGeAlD
Lovastatin—CYP2C8—kidney—type 2 diabetes mellitus	0.000131	0.00807	CbGeAlD
Lovastatin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000119	0.00733	CbGeAlD
Lovastatin—SLCO1A2—liver—type 2 diabetes mellitus	0.000119	0.0073	CbGeAlD
Lovastatin—CYP3A5—kidney—type 2 diabetes mellitus	0.000118	0.00728	CbGeAlD
Lovastatin—Simvastatin—CYP3A4—type 2 diabetes mellitus	0.000118	0.0617	CrCbGaD
Lovastatin—CYP3A5—pancreas—type 2 diabetes mellitus	0.000118	0.00724	CbGeAlD
Lovastatin—Pravastatin—CYP3A4—type 2 diabetes mellitus	0.000116	0.0604	CrCbGaD
Lovastatin—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000115	0.00709	CbGeAlD
Lovastatin—ABCC2—liver—type 2 diabetes mellitus	0.000111	0.0068	CbGeAlD
Lovastatin—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000107	0.00656	CbGeAlD
Lovastatin—CYP2C19—liver—type 2 diabetes mellitus	9.5e-05	0.00584	CbGeAlD
Lovastatin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	8.89e-05	0.00547	CbGeAlD
Lovastatin—CYP3A4—kidney—type 2 diabetes mellitus	8.88e-05	0.00547	CbGeAlD
Lovastatin—CYP2D6—kidney—type 2 diabetes mellitus	8.74e-05	0.00538	CbGeAlD
Lovastatin—CYP2C8—liver—type 2 diabetes mellitus	8.29e-05	0.0051	CbGeAlD
Lovastatin—ABCB1—retina—type 2 diabetes mellitus	7.6e-05	0.00468	CbGeAlD
Lovastatin—CYP3A5—liver—type 2 diabetes mellitus	7.48e-05	0.0046	CbGeAlD
Lovastatin—CYP2C9—liver—type 2 diabetes mellitus	7.36e-05	0.00453	CbGeAlD
Lovastatin—ABCB1—nephron tubule—type 2 diabetes mellitus	7.15e-05	0.0044	CbGeAlD
Lovastatin—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.43e-05	0.00395	CbGeAlD
Lovastatin—ABCB1—kidney—type 2 diabetes mellitus	6.29e-05	0.00387	CbGeAlD
Lovastatin—ABCB1—pancreas—type 2 diabetes mellitus	6.25e-05	0.00384	CbGeAlD
Lovastatin—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.12e-05	0.00377	CbGeAlD
Lovastatin—ABCB1—adipose tissue—type 2 diabetes mellitus	5.67e-05	0.00349	CbGeAlD
Lovastatin—CYP3A4—liver—type 2 diabetes mellitus	5.61e-05	0.00346	CbGeAlD
Lovastatin—CYP2D6—liver—type 2 diabetes mellitus	5.52e-05	0.0034	CbGeAlD
Lovastatin—Hepatitis—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000747	CcSEcCtD
Lovastatin—Dizziness—Glimepiride—type 2 diabetes mellitus	5.08e-05	0.000743	CcSEcCtD
Lovastatin—Dysgeusia—Losartan—type 2 diabetes mellitus	5.07e-05	0.000742	CcSEcCtD
Lovastatin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	5.07e-05	0.000742	CcSEcCtD
Lovastatin—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.07e-05	0.000741	CcSEcCtD
Lovastatin—Urticaria—Glyburide—type 2 diabetes mellitus	5.04e-05	0.000737	CcSEcCtD
Lovastatin—Angioedema—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000736	CcSEcCtD
Lovastatin—Back pain—Losartan—type 2 diabetes mellitus	5.01e-05	0.000733	CcSEcCtD
Lovastatin—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.01e-05	0.000733	CcSEcCtD
Lovastatin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.000733	CcSEcCtD
Lovastatin—Anorexia—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000729	CcSEcCtD
Lovastatin—Muscle spasms—Losartan—type 2 diabetes mellitus	4.98e-05	0.000729	CcSEcCtD
Lovastatin—Asthenia—Bromocriptine—type 2 diabetes mellitus	4.97e-05	0.000728	CcSEcCtD
Lovastatin—Chest pain—Metformin—type 2 diabetes mellitus	4.97e-05	0.000727	CcSEcCtD
Lovastatin—Myalgia—Metformin—type 2 diabetes mellitus	4.97e-05	0.000727	CcSEcCtD
Lovastatin—Malaise—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000726	CcSEcCtD
Lovastatin—Vertigo—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000724	CcSEcCtD
Lovastatin—Headache—Pioglitazone—type 2 diabetes mellitus	4.94e-05	0.000723	CcSEcCtD
Lovastatin—Leukopenia—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000721	CcSEcCtD
Lovastatin—Discomfort—Metformin—type 2 diabetes mellitus	4.91e-05	0.000718	CcSEcCtD
Lovastatin—Fatigue—Gliclazide—type 2 diabetes mellitus	4.91e-05	0.000718	CcSEcCtD
Lovastatin—Nausea—Glipizide—type 2 diabetes mellitus	4.89e-05	0.000716	CcSEcCtD
Lovastatin—Vomiting—Glimepiride—type 2 diabetes mellitus	4.89e-05	0.000715	CcSEcCtD
Lovastatin—Vision blurred—Losartan—type 2 diabetes mellitus	4.88e-05	0.000714	CcSEcCtD
Lovastatin—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.87e-05	0.000713	CcSEcCtD
Lovastatin—Constipation—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000712	CcSEcCtD
Lovastatin—Pain—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000712	CcSEcCtD
Lovastatin—Tremor—Losartan—type 2 diabetes mellitus	4.85e-05	0.00071	CcSEcCtD
Lovastatin—Rash—Glimepiride—type 2 diabetes mellitus	4.85e-05	0.000709	CcSEcCtD
Lovastatin—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.84e-05	0.000708	CcSEcCtD
Lovastatin—Rash—Sitagliptin—type 2 diabetes mellitus	4.83e-05	0.000707	CcSEcCtD
Lovastatin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.83e-05	0.000706	CcSEcCtD
Lovastatin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000706	CcSEcCtD
Lovastatin—Headache—Glimepiride—type 2 diabetes mellitus	4.81e-05	0.000704	CcSEcCtD
Lovastatin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.81e-05	0.000703	CcSEcCtD
Lovastatin—Headache—Sitagliptin—type 2 diabetes mellitus	4.8e-05	0.000702	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.76e-05	0.000697	CcSEcCtD
Lovastatin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.74e-05	0.000694	CcSEcCtD
Lovastatin—Flushing—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000693	CcSEcCtD
Lovastatin—Angioedema—Losartan—type 2 diabetes mellitus	4.73e-05	0.000693	CcSEcCtD
Lovastatin—Infection—Metformin—type 2 diabetes mellitus	4.73e-05	0.000692	CcSEcCtD
Lovastatin—Insomnia—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000692	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.71e-05	0.000689	CcSEcCtD
Lovastatin—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.7e-05	0.000687	CcSEcCtD
Lovastatin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.69e-05	0.000686	CcSEcCtD
Lovastatin—Myalgia—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000686	CcSEcCtD
Lovastatin—Chest pain—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000686	CcSEcCtD
Lovastatin—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000686	CcSEcCtD
Lovastatin—Insomnia—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000684	CcSEcCtD
Lovastatin—Malaise—Losartan—type 2 diabetes mellitus	4.67e-05	0.000684	CcSEcCtD
Lovastatin—Anxiety—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000683	CcSEcCtD
Lovastatin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.67e-05	0.000683	CcSEcCtD
Lovastatin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.66e-05	0.000682	CcSEcCtD
Lovastatin—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.66e-05	0.000682	CcSEcCtD
Lovastatin—Vertigo—Losartan—type 2 diabetes mellitus	4.66e-05	0.000681	CcSEcCtD
Lovastatin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.65e-05	0.000681	CcSEcCtD
Lovastatin—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.64e-05	0.000679	CcSEcCtD
Lovastatin—Leukopenia—Losartan—type 2 diabetes mellitus	4.64e-05	0.000678	CcSEcCtD
Lovastatin—Discomfort—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000677	CcSEcCtD
Lovastatin—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000673	CcSEcCtD
Lovastatin—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.58e-05	0.000671	CcSEcCtD
Lovastatin—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000671	CcSEcCtD
Lovastatin—Nausea—Glimepiride—type 2 diabetes mellitus	4.57e-05	0.000668	CcSEcCtD
Lovastatin—Nausea—Sitagliptin—type 2 diabetes mellitus	4.55e-05	0.000666	CcSEcCtD
Lovastatin—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000665	CcSEcCtD
Lovastatin—Asthenia—Glyburide—type 2 diabetes mellitus	4.55e-05	0.000665	CcSEcCtD
Lovastatin—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000665	CcSEcCtD
Lovastatin—Anorexia—Metformin—type 2 diabetes mellitus	4.54e-05	0.000664	CcSEcCtD
Lovastatin—Urticaria—Gliclazide—type 2 diabetes mellitus	4.52e-05	0.000661	CcSEcCtD
Lovastatin—Alopecia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.00066	CcSEcCtD
Lovastatin—Fatigue—Valsartan—type 2 diabetes mellitus	4.51e-05	0.000659	CcSEcCtD
Lovastatin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.5e-05	0.000658	CcSEcCtD
Lovastatin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.5e-05	0.000658	CcSEcCtD
Lovastatin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000657	CcSEcCtD
Lovastatin—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.49e-05	0.000657	CcSEcCtD
Lovastatin—Pruritus—Glyburide—type 2 diabetes mellitus	4.48e-05	0.000656	CcSEcCtD
Lovastatin—Constipation—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000654	CcSEcCtD
Lovastatin—Infection—Irbesartan—type 2 diabetes mellitus	4.46e-05	0.000653	CcSEcCtD
Lovastatin—Fatigue—Orlistat—type 2 diabetes mellitus	4.45e-05	0.000652	CcSEcCtD
Lovastatin—Pain—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000646	CcSEcCtD
Lovastatin—Myalgia—Losartan—type 2 diabetes mellitus	4.41e-05	0.000645	CcSEcCtD
Lovastatin—Chest pain—Losartan—type 2 diabetes mellitus	4.41e-05	0.000645	CcSEcCtD
Lovastatin—Arthralgia—Losartan—type 2 diabetes mellitus	4.41e-05	0.000645	CcSEcCtD
Lovastatin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.41e-05	0.000645	CcSEcCtD
Lovastatin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000644	CcSEcCtD
Lovastatin—Anxiety—Losartan—type 2 diabetes mellitus	4.4e-05	0.000643	CcSEcCtD
Lovastatin—Rash—Bromocriptine—type 2 diabetes mellitus	4.37e-05	0.000639	CcSEcCtD
Lovastatin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.37e-05	0.000639	CcSEcCtD
Lovastatin—Discomfort—Losartan—type 2 diabetes mellitus	4.36e-05	0.000638	CcSEcCtD
Lovastatin—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000636	CcSEcCtD
Lovastatin—Headache—Bromocriptine—type 2 diabetes mellitus	4.34e-05	0.000635	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.34e-05	0.000635	CcSEcCtD
Lovastatin—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.34e-05	0.000634	CcSEcCtD
Lovastatin—Dry mouth—Losartan—type 2 diabetes mellitus	4.31e-05	0.000631	CcSEcCtD
Lovastatin—Anorexia—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000627	CcSEcCtD
Lovastatin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.28e-05	0.000625	CcSEcCtD
Lovastatin—Paraesthesia—Metformin—type 2 diabetes mellitus	4.28e-05	0.000625	CcSEcCtD
Lovastatin—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000625	CcSEcCtD
Lovastatin—Confusional state—Losartan—type 2 diabetes mellitus	4.26e-05	0.000624	CcSEcCtD
Lovastatin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.26e-05	0.000623	CcSEcCtD
Lovastatin—Dyspnoea—Metformin—type 2 diabetes mellitus	4.25e-05	0.000621	CcSEcCtD
Lovastatin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.23e-05	0.000619	CcSEcCtD
Lovastatin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.23e-05	0.000618	CcSEcCtD
Lovastatin—Infection—Losartan—type 2 diabetes mellitus	4.2e-05	0.000615	CcSEcCtD
Lovastatin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.19e-05	0.000613	CcSEcCtD
Lovastatin—Dyspepsia—Metformin—type 2 diabetes mellitus	4.19e-05	0.000613	CcSEcCtD
Lovastatin—Tremor—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000609	CcSEcCtD
Lovastatin—Urticaria—Valsartan—type 2 diabetes mellitus	4.15e-05	0.000608	CcSEcCtD
Lovastatin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.14e-05	0.000606	CcSEcCtD
Lovastatin—Decreased appetite—Metformin—type 2 diabetes mellitus	4.14e-05	0.000605	CcSEcCtD
Lovastatin—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000605	CcSEcCtD
Lovastatin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000603	CcSEcCtD
Lovastatin—Nausea—Bromocriptine—type 2 diabetes mellitus	4.12e-05	0.000602	CcSEcCtD
Lovastatin—Fatigue—Metformin—type 2 diabetes mellitus	4.11e-05	0.000601	CcSEcCtD
Lovastatin—Urticaria—Orlistat—type 2 diabetes mellitus	4.1e-05	0.0006	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000599	CcSEcCtD
Lovastatin—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000597	CcSEcCtD
Lovastatin—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000597	CcSEcCtD
Lovastatin—Asthenia—Gliclazide—type 2 diabetes mellitus	4.08e-05	0.000597	CcSEcCtD
Lovastatin—Constipation—Metformin—type 2 diabetes mellitus	4.07e-05	0.000596	CcSEcCtD
Lovastatin—Angioedema—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000594	CcSEcCtD
Lovastatin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.00059	CcSEcCtD
Lovastatin—Anorexia—Losartan—type 2 diabetes mellitus	4.03e-05	0.00059	CcSEcCtD
Lovastatin—Vomiting—Glyburide—type 2 diabetes mellitus	4.03e-05	0.000589	CcSEcCtD
Lovastatin—Pruritus—Gliclazide—type 2 diabetes mellitus	4.03e-05	0.000589	CcSEcCtD
Lovastatin—Malaise—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000586	CcSEcCtD
Lovastatin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000586	CcSEcCtD
Lovastatin—Rash—Glyburide—type 2 diabetes mellitus	4e-05	0.000585	CcSEcCtD
Lovastatin—Dermatitis—Glyburide—type 2 diabetes mellitus	3.99e-05	0.000584	CcSEcCtD
Lovastatin—Vertigo—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000584	CcSEcCtD
Lovastatin—Leukopenia—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000582	CcSEcCtD
Lovastatin—ABCB1—liver—type 2 diabetes mellitus	3.97e-05	0.00245	CbGeAlD
Lovastatin—Headache—Glyburide—type 2 diabetes mellitus	3.97e-05	0.000581	CcSEcCtD
Lovastatin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000579	CcSEcCtD
Lovastatin—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.92e-05	0.000574	CcSEcCtD
Lovastatin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000571	CcSEcCtD
Lovastatin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.89e-05	0.00057	CcSEcCtD
Lovastatin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.89e-05	0.00057	CcSEcCtD
Lovastatin—Fatigue—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000567	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.85e-05	0.000564	CcSEcCtD
Lovastatin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.85e-05	0.000564	CcSEcCtD
Lovastatin—Pain—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000562	CcSEcCtD
Lovastatin—Constipation—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000562	CcSEcCtD
Lovastatin—Insomnia—Losartan—type 2 diabetes mellitus	3.82e-05	0.000559	CcSEcCtD
Lovastatin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.81e-05	0.000557	CcSEcCtD
Lovastatin—Paraesthesia—Losartan—type 2 diabetes mellitus	3.8e-05	0.000555	CcSEcCtD
Lovastatin—Urticaria—Metformin—type 2 diabetes mellitus	3.78e-05	0.000553	CcSEcCtD
Lovastatin—Chest pain—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000553	CcSEcCtD
Lovastatin—Arthralgia—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000553	CcSEcCtD
Lovastatin—Myalgia—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000553	CcSEcCtD
Lovastatin—Dyspnoea—Losartan—type 2 diabetes mellitus	3.77e-05	0.000552	CcSEcCtD
Lovastatin—Anxiety—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000551	CcSEcCtD
Lovastatin—Nausea—Glyburide—type 2 diabetes mellitus	3.76e-05	0.000551	CcSEcCtD
Lovastatin—Abdominal pain—Metformin—type 2 diabetes mellitus	3.76e-05	0.000551	CcSEcCtD
Lovastatin—Dizziness—Gliclazide—type 2 diabetes mellitus	3.76e-05	0.000551	CcSEcCtD
Lovastatin—Asthenia—Valsartan—type 2 diabetes mellitus	3.75e-05	0.000549	CcSEcCtD
Lovastatin—Discomfort—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000547	CcSEcCtD
Lovastatin—Dyspepsia—Losartan—type 2 diabetes mellitus	3.72e-05	0.000545	CcSEcCtD
Lovastatin—Asthenia—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000542	CcSEcCtD
Lovastatin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.7e-05	0.000542	CcSEcCtD
Lovastatin—Pruritus—Valsartan—type 2 diabetes mellitus	3.7e-05	0.000541	CcSEcCtD
Lovastatin—Dry mouth—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000541	CcSEcCtD
Lovastatin—Decreased appetite—Losartan—type 2 diabetes mellitus	3.68e-05	0.000538	CcSEcCtD
Lovastatin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000538	CcSEcCtD
Lovastatin—Confusional state—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000535	CcSEcCtD
Lovastatin—Pruritus—Orlistat—type 2 diabetes mellitus	3.66e-05	0.000535	CcSEcCtD
Lovastatin—Fatigue—Losartan—type 2 diabetes mellitus	3.65e-05	0.000533	CcSEcCtD
Lovastatin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.63e-05	0.00053	CcSEcCtD
Lovastatin—Vomiting—Gliclazide—type 2 diabetes mellitus	3.62e-05	0.000529	CcSEcCtD
Lovastatin—Pain—Losartan—type 2 diabetes mellitus	3.62e-05	0.000529	CcSEcCtD
Lovastatin—Constipation—Losartan—type 2 diabetes mellitus	3.62e-05	0.000529	CcSEcCtD
Lovastatin—Rash—Gliclazide—type 2 diabetes mellitus	3.59e-05	0.000525	CcSEcCtD
Lovastatin—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.59e-05	0.000524	CcSEcCtD
Lovastatin—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.58e-05	0.000523	CcSEcCtD
Lovastatin—Urticaria—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000522	CcSEcCtD
Lovastatin—Headache—Gliclazide—type 2 diabetes mellitus	3.57e-05	0.000522	CcSEcCtD
Lovastatin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.00052	CcSEcCtD
Lovastatin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.00052	CcSEcCtD
Lovastatin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000519	CcSEcCtD
Lovastatin—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.54e-05	0.000517	CcSEcCtD
Lovastatin—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.48e-05	0.00051	CcSEcCtD
Lovastatin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.46e-05	0.000506	CcSEcCtD
Lovastatin—Dizziness—Valsartan—type 2 diabetes mellitus	3.46e-05	0.000506	CcSEcCtD
Lovastatin—Anorexia—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000506	CcSEcCtD
Lovastatin—Dizziness—Orlistat—type 2 diabetes mellitus	3.42e-05	0.0005	CcSEcCtD
Lovastatin—Asthenia—Metformin—type 2 diabetes mellitus	3.42e-05	0.0005	CcSEcCtD
Lovastatin—Nausea—Gliclazide—type 2 diabetes mellitus	3.38e-05	0.000494	CcSEcCtD
Lovastatin—Pruritus—Metformin—type 2 diabetes mellitus	3.37e-05	0.000493	CcSEcCtD
Lovastatin—Urticaria—Losartan—type 2 diabetes mellitus	3.36e-05	0.000491	CcSEcCtD
Lovastatin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.34e-05	0.000489	CcSEcCtD
Lovastatin—Body temperature increased—Losartan—type 2 diabetes mellitus	3.34e-05	0.000489	CcSEcCtD
Lovastatin—Vomiting—Valsartan—type 2 diabetes mellitus	3.32e-05	0.000486	CcSEcCtD
Lovastatin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.31e-05	0.000484	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000483	CcSEcCtD
Lovastatin—Rash—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000482	CcSEcCtD
Lovastatin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.29e-05	0.000482	CcSEcCtD
Lovastatin—Vomiting—Orlistat—type 2 diabetes mellitus	3.29e-05	0.000481	CcSEcCtD
Lovastatin—Insomnia—Ramipril—type 2 diabetes mellitus	3.28e-05	0.00048	CcSEcCtD
Lovastatin—Headache—Valsartan—type 2 diabetes mellitus	3.28e-05	0.000479	CcSEcCtD
Lovastatin—Diarrhoea—Metformin—type 2 diabetes mellitus	3.26e-05	0.000477	CcSEcCtD
Lovastatin—Rash—Orlistat—type 2 diabetes mellitus	3.26e-05	0.000477	CcSEcCtD
Lovastatin—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000476	CcSEcCtD
Lovastatin—Dermatitis—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000476	CcSEcCtD
Lovastatin—Headache—Orlistat—type 2 diabetes mellitus	3.24e-05	0.000473	CcSEcCtD
Lovastatin—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000473	CcSEcCtD
Lovastatin—Asthenia—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000472	CcSEcCtD
Lovastatin—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000467	CcSEcCtD
Lovastatin—Pruritus—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000465	CcSEcCtD
Lovastatin—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000461	CcSEcCtD
Lovastatin—Dizziness—Metformin—type 2 diabetes mellitus	3.15e-05	0.000461	CcSEcCtD
Lovastatin—Fatigue—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000457	CcSEcCtD
Lovastatin—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.12e-05	0.000456	CcSEcCtD
Lovastatin—Nausea—Valsartan—type 2 diabetes mellitus	3.11e-05	0.000454	CcSEcCtD
Lovastatin—Constipation—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000454	CcSEcCtD
Lovastatin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.00045	CcSEcCtD
Lovastatin—Nausea—Orlistat—type 2 diabetes mellitus	3.07e-05	0.000449	CcSEcCtD
Lovastatin—Asthenia—Losartan—type 2 diabetes mellitus	3.03e-05	0.000444	CcSEcCtD
Lovastatin—Vomiting—Metformin—type 2 diabetes mellitus	3.03e-05	0.000443	CcSEcCtD
Lovastatin—Rash—Metformin—type 2 diabetes mellitus	3e-05	0.000439	CcSEcCtD
Lovastatin—Dermatitis—Metformin—type 2 diabetes mellitus	3e-05	0.000439	CcSEcCtD
Lovastatin—Pruritus—Losartan—type 2 diabetes mellitus	2.99e-05	0.000438	CcSEcCtD
Lovastatin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000437	CcSEcCtD
Lovastatin—Headache—Metformin—type 2 diabetes mellitus	2.98e-05	0.000436	CcSEcCtD
Lovastatin—Dizziness—Irbesartan—type 2 diabetes mellitus	2.97e-05	0.000435	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000434	CcSEcCtD
Lovastatin—Diarrhoea—Losartan—type 2 diabetes mellitus	2.89e-05	0.000423	CcSEcCtD
Lovastatin—Urticaria—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000421	CcSEcCtD
Lovastatin—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000419	CcSEcCtD
Lovastatin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000419	CcSEcCtD
Lovastatin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000418	CcSEcCtD
Lovastatin—Rash—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000414	CcSEcCtD
Lovastatin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000414	CcSEcCtD
Lovastatin—Nausea—Metformin—type 2 diabetes mellitus	2.83e-05	0.000414	CcSEcCtD
Lovastatin—Headache—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000412	CcSEcCtD
Lovastatin—Dizziness—Losartan—type 2 diabetes mellitus	2.8e-05	0.000409	CcSEcCtD
Lovastatin—Vomiting—Losartan—type 2 diabetes mellitus	2.69e-05	0.000393	CcSEcCtD
Lovastatin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000391	CcSEcCtD
Lovastatin—Nausea—Irbesartan—type 2 diabetes mellitus	2.67e-05	0.00039	CcSEcCtD
Lovastatin—Rash—Losartan—type 2 diabetes mellitus	2.67e-05	0.00039	CcSEcCtD
Lovastatin—Dermatitis—Losartan—type 2 diabetes mellitus	2.66e-05	0.00039	CcSEcCtD
Lovastatin—Headache—Losartan—type 2 diabetes mellitus	2.65e-05	0.000388	CcSEcCtD
Lovastatin—Asthenia—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000381	CcSEcCtD
Lovastatin—Pruritus—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000375	CcSEcCtD
Lovastatin—Nausea—Losartan—type 2 diabetes mellitus	2.51e-05	0.000367	CcSEcCtD
Lovastatin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000363	CcSEcCtD
Lovastatin—Dizziness—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000351	CcSEcCtD
Lovastatin—Vomiting—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000337	CcSEcCtD
Lovastatin—Rash—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000334	CcSEcCtD
Lovastatin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000334	CcSEcCtD
Lovastatin—Headache—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000332	CcSEcCtD
Lovastatin—Nausea—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000315	CcSEcCtD
Lovastatin—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	1.33e-06	2.89e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.33e-06	2.88e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.33e-06	2.88e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.33e-06	2.88e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	2.87e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.32e-06	2.86e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.31e-06	2.84e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.31e-06	2.84e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.31e-06	2.84e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	1.31e-06	2.84e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.31e-06	2.83e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.3e-06	2.82e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.3e-06	2.82e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.3e-06	2.82e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	2.81e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.29e-06	2.8e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.29e-06	2.79e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.29e-06	2.79e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.29e-06	2.79e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	1.28e-06	2.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.28e-06	2.77e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	1.28e-06	2.77e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.27e-06	2.76e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.26e-06	2.73e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.26e-06	2.73e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.26e-06	2.72e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.26e-06	2.72e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.26e-06	2.72e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.26e-06	2.72e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.25e-06	2.71e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.25e-06	2.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.25e-06	2.7e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	1.24e-06	2.69e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.24e-06	2.69e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.24e-06	2.69e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	2.68e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	2.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.24e-06	2.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.24e-06	2.68e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-06	2.68e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-06	2.66e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.23e-06	2.66e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.23e-06	2.66e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.22e-06	2.65e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.21e-06	2.61e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.2e-06	2.61e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.2e-06	2.59e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.19e-06	2.58e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	2.58e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.19e-06	2.57e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	2.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.19e-06	2.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.19e-06	2.57e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-06	2.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.18e-06	2.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.18e-06	2.55e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-06	2.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	2.5e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.16e-06	2.5e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—type 2 diabetes mellitus	1.14e-06	2.47e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	2.46e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	2.46e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—type 2 diabetes mellitus	1.14e-06	2.46e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.13e-06	2.46e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	2.45e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	1.12e-06	2.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.12e-06	2.42e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.11e-06	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.11e-06	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.11e-06	2.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.11e-06	2.4e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.11e-06	2.4e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	2.39e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-06	2.39e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.1e-06	2.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.09e-06	2.36e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-06	2.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-06	2.35e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-06	2.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.08e-06	2.34e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.08e-06	2.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.07e-06	2.31e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-06	2.3e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-06	2.3e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.06e-06	2.3e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—type 2 diabetes mellitus	1.05e-06	2.28e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.05e-06	2.26e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-06	2.25e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	2.25e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.04e-06	2.24e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.03e-06	2.23e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.02e-06	2.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.02e-06	2.22e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.02e-06	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.02e-06	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.02e-06	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.02e-06	2.2e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.01e-06	2.2e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.01e-06	2.2e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.01e-06	2.19e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.01e-06	2.19e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-06	2.18e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1e-06	2.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1e-06	2.17e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1e-06	2.17e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.98e-07	2.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.98e-07	2.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.98e-07	2.16e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	9.96e-07	2.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.92e-07	2.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	9.92e-07	2.15e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.89e-07	2.14e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	9.88e-07	2.14e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	9.76e-07	2.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9.74e-07	2.11e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	9.71e-07	2.1e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.68e-07	2.09e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	9.67e-07	2.09e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.64e-07	2.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	9.63e-07	2.08e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	9.62e-07	2.08e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	9.57e-07	2.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	9.55e-07	2.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	9.51e-07	2.06e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	9.5e-07	2.06e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	9.49e-07	2.05e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	9.41e-07	2.04e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	9.4e-07	2.03e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.39e-07	2.03e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	9.38e-07	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	9.32e-07	2.02e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.28e-07	2.01e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	9.24e-07	2e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	9.12e-07	1.97e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	9.12e-07	1.97e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	9.09e-07	1.97e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	9.04e-07	1.96e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	9.01e-07	1.95e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	9e-07	1.95e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.95e-07	1.94e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.95e-07	1.94e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.95e-07	1.94e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	8.95e-07	1.94e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.9e-07	1.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.85e-07	1.92e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.79e-07	1.9e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	8.77e-07	1.9e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.74e-07	1.89e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.73e-07	1.89e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.71e-07	1.88e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	8.66e-07	1.88e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	8.66e-07	1.88e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	8.6e-07	1.86e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.52e-07	1.84e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	8.52e-07	1.84e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	8.49e-07	1.84e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.46e-07	1.83e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	8.39e-07	1.82e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	8.39e-07	1.82e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.32e-07	1.8e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	8.32e-07	1.8e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.29e-07	1.79e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	8.28e-07	1.79e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	8.23e-07	1.78e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	8.23e-07	1.78e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	8.23e-07	1.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	8.19e-07	1.77e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	8.19e-07	1.77e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	8.16e-07	1.77e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	8.13e-07	1.76e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	8.1e-07	1.75e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	8.1e-07	1.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—type 2 diabetes mellitus	8e-07	1.73e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.97e-07	1.72e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	7.9e-07	1.71e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.84e-07	1.7e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.81e-07	1.69e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	7.77e-07	1.68e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.76e-07	1.68e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.76e-07	1.68e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	7.74e-07	1.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	7.72e-07	1.67e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	7.66e-07	1.66e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	7.65e-07	1.66e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	7.52e-07	1.63e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	7.45e-07	1.61e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	7.39e-07	1.6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.38e-07	1.6e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	7.25e-07	1.57e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.22e-07	1.56e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	7.13e-07	1.54e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	7.13e-07	1.54e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	7.08e-07	1.53e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.8e-07	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	6.74e-07	1.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.69e-07	1.45e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.69e-07	1.45e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.67e-07	1.44e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.67e-07	1.44e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.66e-07	1.44e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	6.65e-07	1.44e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	6.61e-07	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.57e-07	1.42e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	6.52e-07	1.41e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.49e-07	1.4e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.38e-07	1.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	6.36e-07	1.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	6.36e-07	1.38e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	6.22e-07	1.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.21e-07	1.34e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.21e-07	1.34e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.21e-07	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	6.12e-07	1.32e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6.09e-07	1.32e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.06e-07	1.31e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.96e-07	1.29e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.94e-07	1.29e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.85e-07	1.27e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.85e-07	1.27e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	5.82e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.8e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.8e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.79e-07	1.25e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.71e-07	1.24e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	5.7e-07	1.23e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.68e-07	1.23e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.48e-07	1.19e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.38e-07	1.16e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	5.35e-07	1.16e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	5.3e-07	1.15e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	5.23e-07	1.13e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.21e-07	1.13e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.12e-07	1.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.11e-07	1.1e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.05e-07	1.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.45e-07	9.62e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.36e-07	9.44e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4e-07	8.65e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.82e-07	8.28e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.82e-07	8.28e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-07	8.18e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.5e-07	7.57e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	3.28e-07	7.09e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.92e-07	6.33e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-07	6.18e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.69e-07	5.82e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.67e-07	5.77e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.76e-07	3.81e-06	CbGpPWpGaD
